Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Conference, Award

The Modern Data Company Chosen as Finalist for the 2024 MIT Sloan CIO Symposium's Innovation Showcase


The Modern Data Company, a leader in data product lifecycle management and the inventor of the world's first data operating system, DataOS®, today announced its selection as a finalist in the 2024 Innovation Showcase at the 21st annual MIT Sloan CIO Symposium.

Recognized for Innovation and Value

This prestigious selection recognizes The Modern Data Company as a leading innovator in the Enterprise IT sector. Among ten early-stage companies chosen, The Modern Data Company stands out for its groundbreaking data management solutions that deliver tangible value to businesses. This recognition grants the company unparalleled exposure to a distinguished audience of the world's foremost IT visionaries and influencers attending the in-person Symposium, taking place May 13-14, 2024.

"We are thrilled to be selected as a finalist for the MIT Sloan CIO Symposium's Innovation Showcase," said Srujan Akula, CEO and Cofounder of The Modern Data Company. "Our product, DataOS®, streamlines complex data tasks, fostering trust and accelerating insights. We're making enterprise data AI-ready and eager to connect with leading IT executives at the Symposium to explore various use cases."

Selection Criteria and Showcase Details

The Innovation Showcase judges meticulously selected The Modern Data Company based on several key criteria:

The Innovation Showcase will be held as part of the MIT Sloan CIO Symposium at The Royal Sonesta in Cambridge, Massachusetts on May 13-14, 2024. For the full agenda and ticketing information, please visit: MIT Sloan CIO Symposium website

About The Modern Data Company

The Modern Data Company revolutionizes data management with DataOS®, the world's first data operating system. This unified platform empowers enterprises to build comprehensive data products and simplify data management. DataOS® frees teams to focus on driving real value from data, accelerating their journey to becoming a truly data-driven and AI-ready organization.

About the MIT Sloan CIO Symposium

The MIT Sloan CIO Symposium is the premier global conference for CIOs and digital business executives to become more effective leaders. CIOs and senior IT executives explore enterprise technology innovations, business practices and receive actionable information that enables them to meet the challenges of today and the future. The Symposium offers a unique learning environment by bringing together the academic thought leadership of MIT with the in-the-trenches experience of leading global CIOs and industry experts. The MIT Sloan CIO Symposium is organized and developed by the MIT Sloan Boston Alumni Association. For more information and to register for this year's Symposium, visit www.mitcio.com

Visit us at:

To learn more:


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: